Return to content in this issue

Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma

Gonzalez-Diaz SN¹, Villarreal-Gonzalez RV¹, De Lira- Quezada CE¹, Rocha-Silva GK¹, Oyervides-Juarez VM², Vidal- Gutierrez O<sup>2

1</sup>Regional Center of Allergy and Clinical Immunology, University Hospital "Dr. Jose Eleuterio Gonzalez”, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico
²Oncology Department, University Hospital "Dr. Jose Eleuterio Gonzalez”, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico

J Investig Allergol Clin Immunol 2021; Vol 31(3) : 265-267
doi: 10.18176/jiaci.0637